© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 8, 673-674,
April 21, 1999
© 1999 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The Ohio State University, Columbus, last month honored Richard D. Klausner, M.D., who received the 1999 Herbert J. Block Memorial Lectureship for Distinguished Achievement in Cancer. Klausner is director of the U.S. National Cancer Institute.
|
Recipients of the honor are chosen in an international competitive process that identifies individuals whose contributions to cancer research, patient care, and/or education have received international recognition, the announcement said
The lectureship award is made by the university's Comprehensive Cancer Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Cech To Head HHMI
The Howard Hughes Medical Institute, Chevy Chase, Md., announced that its trustees selected Nobel laureate Thomas R. Cech, Ph.D., to be the next president of the institute. Cech is a Howard Hughes Medical Investigator and professor of biochemistry, biophysics, and genetics at the University of Colorado Health Sciences Center, Denver.
|
Cech, who received the Nobel prize in chemistry in 1989, will become HHMI president next January, succeeding Purnell W. Choppin, M.D., who has been president since 1987 and who announced last year that he would retire at the end of 1999.
Hanna H. Gray, chair of the HHMI board and the presidential search committee, called Cech "a distinguished scientist of great accomplishment, with a profound understanding of the research world."
The institute has an endowment of more than $11 billion, making it the second largest philanthropy in the world after the Wellcome Trust. Its operating budget this year is $556 million (see News, Feb. 17, 1999).
LSA Names Two
The Leukemia Society of America, New York, recently appointed executive directors of two state chapters. Dennis M. Norris became executive director of the Indiana chapter in Indianapolis, Ind., and Judith Swiecicki became executive director of its Gateway Chapter in St. Louis, Mo.
The LSA, which is recognizing its 50th anniversary this year, is a voluntary health organization focused on blood-related cancers. Its Web site is at www.leukemia.org.
RPCI Corporation Formed
The Roswell Park Cancer Institute, Buffalo, N.Y., named Patrick P. Lee as chairman of the Board of Directors of the newly formed Roswell Park Cancer Institute Corporation, an entity formed to give RPCI new ability "to react to the changing health-care market place more efficiently than could be done as a state entity."
|
Both the corporation and its board were created by New York state law, with the board providing oversight of the corporation. Lee, who is chairman and chief executive officer of International Motion Control, was appointed chair by N.Y. Governor George E. Pataki.
David C. Hohn, M.D., RPCI's president, said that without the legislation that created the new corporation, "I am not sure Roswell Park Cancer Institute would have survived."
Senior Vice Presidents Named
The University of Texas M. D. Anderson Cancer Center, Houston, promoted David L. Callender, M.D., and Margaret L. Kripke, Ph.D., to new senior vice presidential positions.
Callender was named senior vice president and chief medical officer and Kripke was named senior vice president and chief academic officer. Both join the seven-member management committee of M. D. Anderson.
Bhalla Joins Sylvester Center
The University of Miami/Sylvester comprehensive Cancer Center, Miami, named Kapil N. Bhalla, M.D., as associate director of the clinical and translational research division. Recently, Bhalla had held a similar position at Emory University's Winship Cancer Center, Atlanta.
The division he heads includes laboratory scientists, physicians, a clinical trials office, statisticians, and data managers, and is intended to move research quickly from the institution's laboratories to use by patients, the announcement said.
Ferrone Heads Immunology
The Roswell Park Cancer Institute, Buffalo, N.Y., named Soldano Ferrone, M.D., Ph.D., as chairman of its Department of Immunology. Ferrone had been professor and chairman of the Department of Microbiology and Immunology at New York Medical College, Valhalla.
David C. Hohn, M.D., president of RPCI, said that Ferrone "will strengthen RPCI's ongoing commitment to developing close and extensive linkages between basic cancer research and clinical investigators."
UPCI Acquires Egorin
The University of Pittsburgh Cancer Institute appointed Merrill Egorin, M.D., to guide the development and evaluation of anti-cancer drugs, and to be professor of medicine and pharmacology at the university's School of Medicine.
Egorin had been at the University of Maryland School of Medicine, Baltimore. In his new position, he will lead programs that "translate basic research discoveries of potential drugs into the development of more effective cancer therapies," the announcement said.
Pathology Chair Named
The University of Texas M. D. Anderson Cancer Center, Houston, named Janet Bruner, M.D., as chair of the Department of Pathology and deputy head of the Division of Pathology and Laboratory Medicine.
Bruner, who has been on the M. D. Anderson faculty for 15 years, is the first woman the institution appointed as a clinical department chair and full-time deputy division head, the announcement said.
EntreMed Appoints Horobin
EntreMed, Inc., Rockville, Md., appointed Joanna C. Horobin, M.D., as senior vice president of commercial development, a newly created position. Horobin will direct commercial development efforts, including strategic partnerships, product portfolio management, and marketing for product launches, the announcement said. EntreMed conducts anti-angiogenesis research.
ASCO OnLine
The American Society of Clinical Oncology, Alexandria, Va., announced that, for the first time this year, the latest news from ASCO's annual meeting will be available by visiting the society's Virtual Meeting at its Web site, ASCO OnLine, www.asco.org.
ASCO said that the Virtual Meeting has been available online since early April and that selected material will remain live on the Internet for a year after the annual meeting, scheduled from May 15 to 18.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||